Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/13/17 → 08/14/20 |
Funding
- Incyte Corporation: $89,506.50
An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic Non Small Cell Lung Cancer
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Salman, Huda (CoPI)
Project: Research